Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr;12(4):825-834.
doi: 10.1007/s13555-022-00711-3. Epub 2022 Mar 31.

Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework

Affiliations
Review

Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework

Brett A King et al. Dermatol Ther (Heidelb). 2022 Apr.

Abstract

Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss. As a clinically heterogeneous disease, various classification systems have evolved for defining its severity. In this high-level review of the literature, we discuss the traditional classification systems for AA severity and their strengths and weaknesses. Most recent classifications have focused on the extent of scalp hair loss as a defining feature, but additional clinical aspects of the disease, including location, pattern, and duration of hair loss as well as impact on the patient's quality of life, are also relevant. These various components have typically been used unidimensionally to classify patients. We propose a multidimensional framework to define AA severity that incorporates multiple patient- and illness-related domains. Using such a framework, dermatologists may better assess the severity of the disease for the individual patient beyond the extent of hair loss.

Keywords: Alopecia areata; Alopecia totalis; Alopecia universalis; Classification; Disease severity.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Components for assessing disease severity, including signs and symptoms of AA, impact on quality of life, and treatment history for qualitative evaluation in classification of severity. Questions under each component are attributes for consideration with potential greater implications of severity from top to bottom. AA-IGA Alopecia Areata Investigator Global Assessment, mo months, SALT Severity of Alopecia Tool

References

    1. Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, et al. Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018;78:1–12. doi: 10.1016/j.jaad.2017.04.1141. - DOI - PubMed
    1. Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson SR, Miller A, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken). 2015;67:891–897. doi: 10.1002/acr.22583. - DOI - PMC - PubMed
    1. Besnier E, Brocq L, Jacquet L. La pratique dermatologique. In la pratique dermatologique,1902. p. 920.
    1. Ikeda T. A new classification of alopecia areata. Dermatology. 1965;131:421–445. doi: 10.1159/000254503. - DOI - PubMed
    1. Sharma VK, Muralidhar S, Kumar B. Reappraisal of Ikeda's classification of alopecia areata: analysis of 356 cases from Chandigarh, India. J Dermatol. 1998;25:108–111. doi: 10.1111/j.1346-8138.1998.tb02359.x. - DOI - PubMed